Heterologous versus homologous boosting elicits qualitatively distinct, BA.5–cross-reactive T cells in transplant recipientsElizabeth A. Thompson, Andrea L. Cox, Jennifer L. Alejo et al.|JCI Insight|2023Cited by 11
Lipid-Oxidizing B Cells Enable Successful Vaccine Response Despite ImmunosuppressionElizabeth A. Thompson, Justin R. Bailey, Katerina Roznik et al.|SSRN Electronic Journal|2022Cited by 2
Heterologous versus homologous boosting regimens elicit qualitatively distinct, BA.5 cross reactive T cells in transplant recipientsElizabeth A. Thompson, Andrea L. Cox, Wabathi Ngecu et al.|The Journal of Immunology|2023Cited by 0